Stanca CM - Search Results

1

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites.

Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N. Ala A, et al. Among authors: stanca cm. Hepatology. 2006 Mar;43(3):525-31. doi: 10.1002/hep.21076. Hepatology. 2006. PMID: 16496326

2

Transplantation trends in primary biliary cirrhosis.

Lee J, Belanger A, Doucette JT, Stanca C, Friedman S, Bach N. Lee J, et al. Clin Gastroenterol Hepatol. 2007 Nov;5(11):1313-5. doi: 10.1016/j.cgh.2007.07.015. Epub 2007 Sep 27. Clin Gastroenterol Hepatol. 2007. PMID: 17900996

3

Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.

Stanca CM, Bach N, Krause C, Tandon N, Freni MA, Gutierrez JA, Bodian C, Lopez J, Berk PD, Bodenheimer HC Jr, Branch AD, Odin JA. Stanca CM, et al. Am J Gastroenterol. 2005 May;100(5):1104-9. doi: 10.1111/j.1572-0241.2005.41315.x. Am J Gastroenterol. 2005. PMID: 15842585

4

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis.

Allina J, Stanca CM, Garber J, Hu B, Sautes-Fridman C, Bach N, Odin JA. Allina J, et al. Among authors: stanca cm. J Autoimmun. 2008 Jun;30(4):238-45. doi: 10.1016/j.jaut.2007.10.003. Epub 2007 Nov 26. J Autoimmun. 2008. PMID: 18023559 Free PMC article.

5

Pathogenic role of environmental toxins in immune-mediated liver diseases.

Stanca CM, Babar J, Singal V, Ozdenerol E, Odin JA. Stanca CM, et al. J Immunotoxicol. 2008 Jan;5(1):59-68. doi: 10.1080/15476910802019086. J Immunotoxicol. 2008. PMID: 18382859 Review.

6

Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis.

Stanca CM, Bach N, Allina J, Bodian C, Bodenheimer H Jr, Odin JA. Stanca CM, et al. Dig Dis Sci. 2008 Jul;53(7):1988-93. doi: 10.1007/s10620-007-0003-2. Epub 2008 Apr 5. Dig Dis Sci. 2008. PMID: 18392679

7

Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis?

Stanca CM, Fiel MI, Allina J, Caracta CF, Odin JA. Stanca CM, et al. Semin Liver Dis. 2005 Aug;25(3):364-70. doi: 10.1055/s-2005-916327. Semin Liver Dis. 2005. PMID: 16143951 No abstract available.

8

Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests.

Stanca CM, Fiel MI, Schiano TD. Stanca CM, et al. Dig Dis Sci. 2007 Jan;52(1):176-8. doi: 10.1007/s10620-006-9368-x. Epub 2006 Dec 15. Dig Dis Sci. 2007. PMID: 17171533

9

Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin.

Stanca CM, Fiel MI, Kontorinis N, Agarwal K, Emre S, Schiano TD. Stanca CM, et al. Transplantation. 2007 Jul 27;84(2):180-6. doi: 10.1097/01.tp.0000269609.08495.45. Transplantation. 2007. PMID: 17667809

10

Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study.

Hytiroglou P, Gutierrez JA, Freni M, Odin JA, Stanca CM, Merati S, Schiano TD, Branch AD, Thung SN. Hytiroglou P, et al. Among authors: stanca cm. Hepatol Res. 2009 Jun;39(6):577-84. doi: 10.1111/j.1872-034X.2008.00483.x. Epub 2009 Jan 12. Hepatol Res. 2009. PMID: 19207586 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page